204 related articles for article (PubMed ID: 34896179)
1. Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study.
Karthikeyan S; Dimick MK; Fiksenbaum L; Jeong H; Birmaher B; Kennedy JL; Lanctôt K; Levitt AJ; Miller GE; Schaffer A; Young LT; Youngstrom EA; Andreazza AC; Goldstein BI
Brain Behav Immun; 2022 Feb; 100():278-286. PubMed ID: 34896179
[TBL] [Abstract][Full Text] [Related]
2. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability.
Solmi M; Suresh Sharma M; Osimo EF; Fornaro M; Bortolato B; Croatto G; Miola A; Vieta E; Pariante CM; Smith L; Fusar-Poli P; Shin JI; Berk M; Carvalho AF
Brain Behav Immun; 2021 Oct; 97():193-203. PubMed ID: 34332041
[TBL] [Abstract][Full Text] [Related]
3. Lower pro- to anti-inflammatory ratios associated with reduced neurocognitive flexibility in symptomatic adolescents with bipolar disorder.
Rahmani N; Hatch J; Dimick M; Naiberg MR; Fiksenbaum L; Andreazza AC; Bowie CR; Dickstein DP; Goldstein BI
J Affect Disord; 2021 Sep; 292():430-438. PubMed ID: 34144368
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory Markers and Brain-Derived Neurotrophic Factor as Potential Bridges Linking Bipolar Disorder and Cardiovascular Risk Among Adolescents.
Hatch JK; Scola G; Olowoyeye O; Collins JE; Andreazza AC; Moody A; Levitt AJ; Strauss BH; Lanctot KL; Goldstein BI
J Clin Psychiatry; 2017 Mar; 78(3):e286-e293. PubMed ID: 28199074
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.
Kauer-Sant'Anna M; Kapczinski F; Andreazza AC; Bond DJ; Lam RW; Young LT; Yatham LN
Int J Neuropsychopharmacol; 2009 May; 12(4):447-58. PubMed ID: 18771602
[TBL] [Abstract][Full Text] [Related]
6. Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study.
Jacoby AS; Munkholm K; Vinberg M; Pedersen BK; Kessing LV
J Affect Disord; 2016 Jun; 197():167-74. PubMed ID: 26994434
[TBL] [Abstract][Full Text] [Related]
7. Elevated C-reactive protein among symptomatic youth with bipolar disorder.
Zou Y; Grigorian A; Karthikeyan S; Goldstein BI
J Psychopharmacol; 2022 May; 36(5):645-652. PubMed ID: 35574908
[TBL] [Abstract][Full Text] [Related]
8. Effects of comorbid alcohol use disorder on bipolar disorder: Focusing on neurocognitive function and inflammatory markers.
Liou YJ; Wang TY; Lee SY; Chang YH; Tsai TY; Chen PS; Huang SY; Tzeng NS; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
Psychoneuroendocrinology; 2023 Jun; 152():106083. PubMed ID: 36934699
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cognitive impairments with lipid profiles and inflammatory biomarkers in unipolar and bipolar depression.
Zhang SF; Chen HM; Xiong JN; Liu J; Xiong J; Xie JZ; Wang XM; Tian Q; Xia B; Li Y; Qu N
J Psychiatr Res; 2022 Jun; 150():300-306. PubMed ID: 35429740
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophic and inflammatory markers in bipolar disorder: A prospective study.
van den Ameele S; Coppens V; Schuermans J; De Boer P; Timmers M; Fransen E; Sabbe B; Morrens M
Psychoneuroendocrinology; 2017 Oct; 84():143-150. PubMed ID: 28711724
[TBL] [Abstract][Full Text] [Related]
11. Association of Lipid Peroxidation and Brain-Derived Neurotrophic Factor with Executive Function in Adolescent Bipolar Disorder.
Newton DF; Naiberg MR; Andreazza AC; Scola G; Dickstein DP; Goldstein BI
Psychopharmacology (Berl); 2017 Feb; 234(4):647-656. PubMed ID: 27957714
[TBL] [Abstract][Full Text] [Related]
12. Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder.
Quidé Y; Bortolasci CC; Spolding B; Kidnapillai S; Watkeys OJ; Cohen-Woods S; Berk M; Carr VJ; Walder K; Green MJ
Psychol Med; 2019 Dec; 49(16):2736-2744. PubMed ID: 30560764
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory markers among adolescents and young adults with bipolar spectrum disorders.
Goldstein BI; Lotrich F; Axelson DA; Gill MK; Hower H; Goldstein TR; Fan J; Yen S; Diler R; Dickstein D; Strober MA; Iyengar S; Ryan ND; Keller MB; Birmaher B
J Clin Psychiatry; 2015 Nov; 76(11):1556-63. PubMed ID: 26646032
[TBL] [Abstract][Full Text] [Related]
14. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J
J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor in bipolar disorder: Associations with age at onset and illness duration.
Baykara B; Koc D; Resmi H; Akan P; Tunca Z; Ozerdem A; Ceylan D; Yalcın NG; Binici NC; Guney SA; Mesman E; Hillegers MHJ; Emiroglu NI
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110075. PubMed ID: 32798619
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived Neurotrophic Factor (BDNF) and gray matter volume in bipolar disorder.
Poletti S; Aggio V; Hoogenboezem TA; Ambrée O; de Wit H; Wijkhuijs AJ; Locatelli C; Colombo C; Arolt V; Drexhage HA; Benedetti F
Eur Psychiatry; 2017 Feb; 40():33-37. PubMed ID: 27837670
[TBL] [Abstract][Full Text] [Related]
17. Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies.
Fernandes BS; Molendijk ML; Köhler CA; Soares JC; Leite CM; Machado-Vieira R; Ribeiro TL; Silva JC; Sales PM; Quevedo J; Oertel-Knöchel V; Vieta E; González-Pinto A; Berk M; Carvalho AF
BMC Med; 2015 Nov; 13():289. PubMed ID: 26621529
[TBL] [Abstract][Full Text] [Related]
18. Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women.
Kenna HA; Reynolds-May M; Stepanenko A; Ketter TA; Hallmayer J; Rasgon NL
J Affect Disord; 2014 Mar; 156():214-8. PubMed ID: 24398043
[TBL] [Abstract][Full Text] [Related]
19. Add-On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12-Week Follow-Up Study.
Lee SY; Wang TY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
Alcohol Clin Exp Res; 2018 Jun; 42(6):1044-1050. PubMed ID: 29656414
[TBL] [Abstract][Full Text] [Related]
20. The Differential Levels of Inflammatory Cytokines and BDNF among Bipolar Spectrum Disorders.
Wang TY; Lee SY; Chen SL; Chung YL; Li CL; Chang YH; Wang LJ; Chen PS; Chen SH; Chu CH; Huang SY; Tzeng NS; Hsieh TH; Chiu YC; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 26865313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
